Citius Pharmaceuticals
CTXR
CTXR
72 hedge funds and large institutions have $17.9M invested in Citius Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 16 increasing their positions, 18 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
26% less capital invested
Capital invested by funds: $24.2M → $17.9M (-$6.35M)
Holders
72
Holding in Top 10
–
Calls
$14K
Puts
–
Top Buyers
| 1 | +$5.93M | |
| 2 | +$1.2M | |
| 3 | +$642K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$367K |
| 5 |
YIH
Y-Intercept (HK)
Hong Kong
|
+$227K |
Top Sellers
| 1 | -$4.04M | |
| 2 | -$950K | |
| 3 | -$759K | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
-$435K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$396K |